We are live on
!
Find out more
Baird Financial Group Portfolio holdings
AUM
$64B
1-Year Est. Return
22.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.44%
1 Year Est. Return
+22.64%
3 Year Est. Return
+71.5%
5 Year Est. Return
+89.73%
10 Year Est. Return
+347.75%
AUM
$10.2B
AUM Growth
–
Cap. Flow
+$10.3B
Cap. Flow
% of AUM
101.68%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
1,304
New
1,304
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$216M |
| 2 |
Apple
AAPL
|
+$200M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$156M |
| 4 |
GE Aerospace
GE
|
+$154M |
| 5 |
AbbVie
ABBV
|
+$136M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.41% |
| 2 | Industrials | 12.09% |
| 3 | Healthcare | 11.38% |
| 4 | Financials | 10.27% |
| 5 | Consumer Discretionary | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.38B
| $7.82M | 0.08% |
+184,117
| New | +$8.17M |
|
252
Southern Company
SO
$110B
| $7.7M | 0.08% |
+183,672
| New | +$8M |
|
253
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
| $7.69M | 0.08% |
+104,259
| New | +$7.86M |
|
254
Axos Financial
AX
$5.45B
| $7.68M | 0.08% |
+290,564
| New | +$6.91M |
|
255
Qorvo
QRVO
$7.63B
| $7.65M | 0.08% |
+95,252
| New | +$7.38M |
|
256
State Street SPDR S&P Pharmaceuticals ETF
XPH
$469M
| $7.58M | 0.07% |
+121,652
| New | +$7.58M |
|
257
Regeneron Pharmaceuticals
REGN
$68.8B
| $7.53M | 0.07% |
+14,768
| New | +$7.21M |
|
258
Medtronic
MDT
$107B
| $7.49M | 0.07% |
+101,009
| New | +$7.72M |
|
259
Clorox
CLX
$11.6B
| $7.42M | 0.07% |
+71,292
| New | +$7.69M |
|
260
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $7.41M | 0.07% |
+242,177
| New | +$7.43M |
|
261
First Trust Dorsey Wright Focus 5 ETF
FV
$3.61B
| $7.38M | 0.07% |
+301,627
| New | +$7.32M |
|
262
Ryder
R
$10.3B
| $7.34M | 0.07% |
+84,063
| New | +$7.93M |
|
263
Novartis
NVS
$295B
| $7.23M | 0.07% |
+82,047
| New | +$7.53M |
|
264
Stryker
SYK
$127B
| $7.15M | 0.07% |
+74,780
| New | +$7.09M |
|
265
Yum! Brands
YUM
$41B
| $7.13M | 0.07% |
+110,166
| New | +$6.98M |
|
266
Norfolk Southern
NSC
$78.8B
| $7.13M | 0.07% |
+81,648
| New | +$7.96M |
|
267
Alerian MLP ETF
AMLP
$13B
| $7.09M | 0.07% |
+91,086
| New | +$7.58M |
|
268
Thermo Fisher Scientific
TMO
$211B
| $7.07M | 0.07% |
+54,499
| New | +$7.1M |
|
269
Becton Dickinson
BDX
$43.1B
| $7.01M | 0.07% |
+50,742
| New | +$7.01M |
|
270
Travelers Companies
TRV
$80.8B
| $6.99M | 0.07% |
+72,284
| New | +$7.4M |
|
271
Republic Services
RSG
$66.7B
| $6.93M | 0.07% |
+176,909
| New | +$7.12M |
|
272
First Trust Dow Jones Internet Index Fund ETF
FDN
$4.86B
| $6.8M | 0.07% |
+101,126
| New | +$6.79M |
|
273
General Motors
GM
$74.7B
| $6.69M | 0.07% |
+200,664
| New | +$7.16M |
|
274
Vanguard Real Estate ETF
VNQ
$39.9B
| $6.68M | 0.07% |
+89,493
| New | +$7.15M |
|
|
TPH
275
DELISTED
Tri Pointe Homes
TPH
| $6.67M | 0.07% |
+436,276
| New | +$6.49M |
|
Similar funds
Baird Financial Group's Q2 2015 Portfolio in Review
Q2 2015 is the first quarter with a 13F filing on record for Baird Financial Group, which disclosed 1,304 positions worth $10.2B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is iShares Russell 1000 Value ETF: 2,063,911 shares worth $213M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, followed by Industrials and Healthcare.
- Baird Financial Group's largest Q2 2015 buy was iShares Russell 1000 Value ETF: 2,063,911 shares worth $213M.
- Baird Financial Group's ten largest holdings make up 14% of its $10.2B portfolio in Q2 2015.
- Baird Financial Group disclosed 1,304 positions in Q2 2015, its first 13F filing on record.
Based on Baird Financial Group's 13F filing for Q2 2015, filed 14 Aug 2015.